In preferred embodiment, the tartrate salt form of vinorelbine is used in the composition.

Intensively binds to blood cells and especially to platelets (78%).

— Use of CFC-113 in the manufacture of vinorelbine (pharmaceutical product),

The invention described herein relates to a pharmaceutical composition containing vinorelbine as an active ingredient which is suitable for encapsulation in soft capsules.

The most common chemotherapy drug combination used is cisplatin and vinorelbine (Navelbine).

The intravenous drugs in question are etoposide, vinorelbine and leucovorin.

Three drugs used in cancer therapy — vinorelbine, leucovorin, and etoposide — are in short supply.

Some of the drugs in use are paclitaxel, docetaxel, vinblastine, vincristine, and vinorelbine.

Research focuses on optimization of solid lipid nanoparticle that encapsulates Vinorelbine bitartrate

The excretion of mebeverine in milk has not been studied in animals.

The invention concerns novel halogenated derivatives of the vinblastine and vinorelbine family, corresponding to general formula (1) and their therapeutically acceptable salts.

The choice between vinorelbine and gemcitabine was made by each centre at the beginning of the study.

Some agents that inhibited microtubule synthesis, such as vinorelbine, caused rapid, massive hemorrhagic necrosis when used in combination with spores.

Some agents that inhibited microtubule synthesis such as HTI-286 and vinorelbine, caused rapid, massive hemorrhagic necrosis when used in combination with spores.

In clinical studies, the oral aprepitant regimen was administered commonly with etoposide, vinorelbine, or paclitaxel.